Weill Medical College Of Cornell University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1865-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://weill.cornell.edu
Differences in Efficacy Between Nasal and Oronasal Masks in the Treatment of OSA With CPAP
Not Applicable
Completed
- Conditions
- Obstructive Sleep Apnea (OSA)
- Interventions
- Device: Switch CPAP mask type
- First Posted Date
- 2013-07-26
- Last Posted Date
- 2017-05-17
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 21
- Registration Number
- NCT01909674
- Locations
- 🇺🇸
Weill Cornell Center for Sleep Medicine, New York, New York, United States
Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22
Phase 1
Terminated
- Conditions
- Glioblastoma MultiformeFibrillary Astrocytoma of BrainGlioma of BrainstemAnaplastic AstrocytomaPilomyxoid AstrocytomaMixed Oligodendroglioma-AstrocytomaBrain Stem GliomaDiffuse Intrinsic Pontine Glioma
- Interventions
- Drug: SIACI of Erbitux and Bevacizumab
- First Posted Date
- 2013-06-24
- Last Posted Date
- 2022-08-09
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 13
- Registration Number
- NCT01884740
- Locations
- 🇺🇸
Weill Cornell Medical College/New York Presbyterian Hospital, New York, New York, United States
Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration
Phase 2
Completed
- Conditions
- HypogonadismOpioid-Related DisordersMale Infertility
- Interventions
- Drug: Clomiphene citrateDrug: Placebo
- First Posted Date
- 2013-06-18
- Last Posted Date
- 2018-07-17
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 13
- Registration Number
- NCT01880086
- Locations
- 🇺🇸
Weill Cornell Medical College, Department of Urology, New York, New York, United States
Safety and Efficacy of Eltrombopag at Escalated Doses
Phase 2
Completed
- Conditions
- Immune ThrombocytopeniaPlatelet Disorder
- Interventions
- Drug: PlaceboDrug: Eltrombopag
- First Posted Date
- 2013-06-18
- Last Posted Date
- 2019-06-11
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 35
- Registration Number
- NCT01880047
- Locations
- 🇺🇸
Weill Cornell Medicine, New York, New York, United States
FemVue and Tubal Patency
Not Applicable
Terminated
- Conditions
- Tubal Patency
- Interventions
- Device: FemVue device
- First Posted Date
- 2013-06-18
- Last Posted Date
- 2020-05-27
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 24
- Registration Number
- NCT01880073
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
3 Dimensional Sonography Imaging
Completed
- Conditions
- New Imaging Modality
- Interventions
- Other: 3D Sonography analysis
- First Posted Date
- 2013-06-07
- Last Posted Date
- 2017-05-08
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 2
- Registration Number
- NCT01872559
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Adapting DBT for Children With DMDD: Pilot RCT
Not Applicable
Completed
- Conditions
- Disruptive Mood Dysregulation Disorder
- Interventions
- Behavioral: Treatment as UsualBehavioral: Dialectical Behavior Therapy for children
- First Posted Date
- 2013-05-24
- Last Posted Date
- 2019-03-01
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 43
- Registration Number
- NCT01862549
- Locations
- 🇺🇸
Weill Cornell Medical College, White Plains, New York, United States
Marcaine Use in Laparoscopic Gynecological Surgery
Not Applicable
Terminated
- Conditions
- Post-operative Pain
- Interventions
- Drug: Marcaine- 0.25%Drug: Marcaine 0.25%.
- First Posted Date
- 2013-05-23
- Last Posted Date
- 2018-10-12
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 27
- Registration Number
- NCT01861665
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Ramipril for the Treatment of Oligospermia
Not Applicable
Terminated
- Conditions
- OligospermiaTeratospermiaAsthenozoospermiaMale Infertility
- Interventions
- Drug: PlaceboDrug: Ramipril
- First Posted Date
- 2013-05-17
- Last Posted Date
- 2017-06-02
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 2
- Registration Number
- NCT01856361
- Locations
- 🇺🇸
Weill Cornell Medical College, Department of Urology, New York, New York, United States
Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation
Phase 2
Active, not recruiting
- Conditions
- Hematologic Malignancies
- Interventions
- Device: CliniMACS® CD34 Reagent SystemDrug: FludarabineDrug: MelphalanDrug: anti-thymocyte globulin (rabbit)Drug: RituximabRadiation: Total Body IrradiationDrug: Mycophenolate MofetilDrug: Tacrolimus
- First Posted Date
- 2013-03-13
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 270
- Registration Number
- NCT01810588
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
🇺🇸University of Chicago Medical Center, Chicago, Illinois, United States
© Copyright 2025. All Rights Reserved by MedPath